当前位置:首页 - 行情中心 - 联环药业(600513) - 财务分析

联环药业

(600513)

  

流通市值:50.50亿  总市值:50.50亿
流通股本:2.85亿   总股本:2.85亿

联环药业(600513)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.28亿元,每股收益-0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益173723.28万元,未分配利润68472.13万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产410919.55万元,负债237196.26万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,082,459,109.351,285,342,346.98627,705,511.572,160,457,160.63
营业总成本2,028,444,912.551,230,280,455.15587,869,188.522,050,251,134.72
其他经营收益
营业利润59,458,501.6953,247,534.3641,277,165.36131,019,022.27
利润总额-1,497,221.37-7,505,817.941,458,668.98130,427,783.25
净利润-27,722,396.42-32,357,597.0427,393,898.07106,414,745.34
每股收益
其他综合收益-104,216.08-96,708.4-93,937.2178,920.88
综合收益总额-27,826,612.5-32,454,305.4427,299,960.86106,493,666.22
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,071,311,398.651,823,669,253.171,738,435,699.241,478,067,504.75
非流动资产:
非流动资产合计2,037,884,083.421,930,497,163.231,885,146,257.971,541,405,046.38
资产总计4,109,195,482.073,754,166,416.43,623,581,957.213,019,472,551.13
流动负债:
流动负债合计1,818,122,785.81,550,209,214.051,481,546,064.21,339,770,538.48
非流动负债:
非流动负债合计553,839,851.43510,762,647.23356,151,428.21102,486,523.63
负债合计2,371,962,637.232,060,971,861.281,837,697,492.411,442,257,062.11
所有者权益(或股东权益):
归属于母公司股东权益合计1,335,037,578.71,330,078,873.041,418,575,187.311,395,609,544.93
股东权益合计1,737,232,844.841,693,194,555.121,785,884,464.81,577,215,489.02
负债和股东权益合计4,109,195,482.073,754,166,416.43,623,581,957.213,019,472,551.13
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,081,145,862.631,297,002,897.03656,872,880.312,341,878,198.17
经营活动现金流出小计2,254,027,017.881,454,812,510.03709,968,744.242,331,112,426.01
经营活动产生的现金流量净额-172,881,155.25-157,809,613-53,095,863.9310,765,772.16
投资活动产生的现金流量:
投资活动现金流入小计16,4686,4682,86822,012,747.47
投资活动现金流出小计292,776,850.53206,284,153.28194,255,050.09206,845,345.89
投资活动产生的现金流量净额-292,760,382.53-206,277,685.28-194,252,182.09-184,832,598.42
筹资活动产生的现金流量:
筹资活动现金流入小计1,306,418,218.01986,181,555.46534,387,620.14852,979,092.69
筹资活动现金流出小计776,524,106.49560,829,907.45231,799,957.64743,037,128.67
筹资活动产生的现金流量净额529,894,111.52425,351,648.01302,587,662.5109,941,964.02
汇率变动对现金及现金等价物的影响160,194.55221,602.02199,397.61628,724.91
现金及现金等价物净增加额64,412,768.2961,485,951.7555,439,014.09-63,496,137.33
期末现金及现金等价物余额251,106,653.53248,179,836.99242,132,899.33186,693,885.24
补充资料:
现金及现金等价物的净增加额-61,485,951.75--63,496,137.33
TOP↑